Large scale population based surveys linked to administrative health databases as a source of data on health utilities in Australia

8 September 2022 - It is ideal that modelling studies apply health utility values that are compatible, derived using common methods, ...

Read more →

Is IQWiG's 15% threshold universally applicable in assessing the clinical relevance of patient reported outcomes changes? An ISPOR Special Interest Group report.

8 September 2022 - To assess the clinical relevance of patient reported outcomes, a response threshold of ≥ 15% of the ...

Read more →

Criticism of study planning: patient-reported endpoints are often collected far too briefly

3 March 2022 - A striking example: abemaciclib in advanced breast cancer. Shortened data on quality of life, symptoms and side ...

Read more →

Patient reported endpoints underrepresented in product information on new drugs

15 December 2021 - An IQWiG team analysed the extent to which patient reported outcomes, which were recorded as endpoints ...

Read more →

Health‐related quality of life in oncology drug reimbursement submissions in Canada: a review of submissions to the pan‐Canadian Oncology Drug Review

23 September 2019 - In Canada, CADTH evaluates and makes recommendations for the reimbursement of cancer drugs. One component of ...

Read more →

In praise of studies that use more than one generic preference-based measure

12 July 2019 - Generic preference-based measures of health-related quality of life are widely used as outcome measures in cost-effectiveness and ...

Read more →

The EORTC Quality of Life Questionnaire for cancer patients (QLQ‐C30): Australian general population reference values

17 June 2019 - Mercieca‐Bebber and colleagues set out generate Australian general population reference values for the EORTC Quality of ...

Read more →